Cited by 2,497Cell death mechanisms and regulationToxin Mechanisms and ImmunotoxinsCancer-related Molecular Pathways

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

Walczak, Henning, Miller, Robert E., Ariail, Kiley, Gliniak, Brian, Griffith, Thomas S., Kubin, Marek, Chin, Wilson, Jones, Jon, Woodward, Anne, Le, Tiep, Smith, Craig, Smolak, Pam, Goodwin, Raymond G., Rauch, Charles T., Schuh, JoAnn C.L., Lynch, David H.·1999·Nature Medicine

DOI 10.1038/5517

Open this paper in CoChat — free account

Abstract

To evaluate the utility of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a cancer therapeutic, we created leucine zipper (LZ) forms of human (hu) and murine (mu) TRAIL to promote and stabilize the formation of trimers. Both were biologically active, inducing apoptosis of both human and murine target cells in vitro with similar specific activities. In contrast to the fulminant hepatotoxicity of LZ-huCD95L in vivo, administration of either LZ-huTRAIL or LZ-muTRAIL did not seem toxic to normal tissues of mice. Finally, repeated treatments with LZ-huTRAIL actively suppressed growth of the TRAIL-sensitive human mammary adenocarcinoma cell line MDA-231 in CB.17 (SCID) mice, and histologic examination of tumors from SCID mice treated with LZ-huTRAIL demonstrated clear areas of apoptotic necrosis within 9-12 hours of injection.

Integrity signals

Registry

Crossref · 10.1038/5517

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Apoptosis by Death Factor
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,934
Bone marrow transplant
Joyce, A. (1989) · Nursing Children and Young People · doi:10.7748/paed.1.6.21.s21 · Cited by 3,408
Identification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900
Self-citation
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 1,990
Self-citation
The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,909
Self-citation
Tumor Necrosis Factor (TNF)
Old, L. J. (1985) · Science · doi:10.1126/science.2413547 · Cited by 1,885
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
Dhein, J., Walczak, H., Bäumler, C., Debatin, K., & Krammer, P. (1995) · Nature · doi:10.1038/373438a0 · Cited by 1,814
Self-citation
Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., & Ashkenazi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12687 · Cited by 1,777
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
Kägi, D., Ledermann, B., Bürki, K., Seiler, P. J., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., & Hengartner, H. (1994) · Nature · doi:10.1038/369031a0 · Cited by 1,758

Flagged first, then by citations

Show all 48 references

Sorted by citations

Items 401–500 of 1,003

The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice
Hylander, B. L., Pitoniak, R., Penetrante, R. B., Gibbs, J. F., Oktay, D., Cheng, J., & Repasky, E. A. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-22 · Cited by 109
Apo2 Ligand/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Cooperates with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve Survival
Jin, H., Yang, R., Fong, S., Tótpál, K., Lawrence, D. A., Zheng, Z., Ross, J., Koeppen, H., SCHWALL, R. H., & Ashkenazi, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0408 · Cited by 109
Bortezomib Abolishes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via a p21-Dependent Mechanism in Human Bladder and Prostate Cancer Cells
Lashinger, L. M., Zhu, K., Williams, S. A., Shrader, M., Dinney, C. P., & McConkey, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3701 · Cited by 109
Primary human hepatocytes – a valuable tool for investigation of apoptosis and hepatitis B virus infection
Schulze‐Bergkamen, H., Untergasser, A., Dax, A., Vogel, H., Büchler, P., Klar, E., Lehnert, T., Friess, H., Büchler, M. W., Kirschfink, M., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00120-x · Cited by 110
Regulation of TRAIL Expression by the Phosphatidylinositol 3-Kinase/Akt/GSK-3 Pathway in Human Colon Cancer Cells
Wang, Q., Wang, X., Hernandez, A., Hellmich, M. R., Gatalica, Z., & Evers, B. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206306200 · Cited by 109
T cell life and death signalling via TNF-receptor family members
Screaton, G. R., & Xu, X. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00093-5 · Cited by 109
Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP
Lee, T.-J., Um, H. J., Min, D. S., Park, J. W., Choi, K. S., & Kwon, T. K. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.022 · Cited by 108
Clustering of Death Receptor for Apoptosis Using Nanoscale Patterns of Peptides
Wang, Y., Baars, I., Fördős, F., & Högberg, B. (2021) · ACS Nano · doi:10.1021/acsnano.0c10104 · Cited by 107
TNF ligands and receptors in autoimmunity: an update
Mackay, F., & Kalled, S. L. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00407-7 · Cited by 108
TNF-Related Apoptosis-Inducing Ligand Mediates Tumoricidal Activity of Human Monocytes Stimulated by Newcastle Disease Virus
Washburn, B., Weigand, M. A., Große-Wilde, A., Janke, M., Stahl, H. F., Rieser, E., Sprick, M. R., Schirrmacher, V., & Walczak, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1814 · Cited by 108
Self-citation
Pro-survival Function of Akt/Protein Kinase B in Prostate Cancer Cells
Thakkar, H., Chen, X., Tyan, F., Gim, S., Robinson, H. M., Lee, C., Pandey, S., Nwokorie, C., Onwudiwe, N. C., & Srivastava, R. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103321200 · Cited by 108
Retracted
Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
Ray, S., & Almasan, A. (2003) · PubMed · Cited by 108
Methionine Deprivation Induces a Targetable Vulnerability in Triple-Negative Breast Cancer Cells by Enhancing TRAIL Receptor-2 Expression
Strekalova, E., Malin, D., Good, D. M., & Cryns, V. L. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2792 · Cited by 107
Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5
Jung, Y.-H., Heo, J., Lee, Y. J., Kwon, T. K., & Kim, Y.-H. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.01.008 · Cited by 107
Human Astrocytes Are Resistant to Fas Ligand and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis
Song, J. H., Bellail, A. C., Tse, M. C. L., Yong, V. W., & Hao, C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5572-05.2006 · Cited by 106
TRAIL-mediated apoptosis requires NF- k B inhibition and the mitochondrial permeability transition in human hepatoma cells
Kim, Y. S., Schwabe, R. F., Qian, T., Lemasters, J. J., & Brenner, D. A. (2002) · Hepatology · doi:10.1002/hep.1840360627 · Cited by 108
DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress
Kappes, F., Fahrer, J., Khodadoust, M. S., Tabbert, A., Strasser, C., Mor‐Vaknin, N., Moreno‐Villanueva, M., Bürkle, A., Markovitz, D. M., & Ferrando‐May, E. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01921-07 · Cited by 108
MicroRNA-223 Increases the Sensitivity of Triple-Negative Breast Cancer Stem Cells to TRAIL-Induced Apoptosis by Targeting HAX-1
Sun, X., Li, Y., Zheng, M., Zuo, W., & Zheng, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162754 · Cited by 106
Inhibition of NF-κB Activity Enhances TRAIL Mediated Apoptosis in Breast Cancer Cell Lines
Keane, M., Rubinstein, Y., Cuello, M. A., Ettenberg, S. A., Banerjee, P., Nau, M. M., & Lipkowitz, S. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006458407515 · Cited by 106
TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors
Plasilova, M. L., Živný, J., Jelı́nek, J., Neuwirtová, R., Čermák, J., Nečas, E., Anděra, L., & Stopka, T. (2002) · Leukemia · doi:10.1038/sj.leu.2402338 · Cited by 106
Failure of Bcl‐2 to block cytochrome c redistribution during TRAIL‐induced apoptosis
Keogh, S. A., Walczak, H., Bouchier‐Hayes, L., & Martin, S. J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01375-2 · Cited by 105
Self-citation
Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation
Chen, L., Meng, Y., Sun, Q., Zhang, Z., Guo, X., Sheng, X., Tai, G., Cheng, H., & Zhou, Y. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.234 · Cited by 105
Blockade of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Exacerbates Type 1 Diabetes in NOD Mice
Mi, Q., Ly, D., Lamhamedi-Cherradi, S.-E., Salojin, K. V., Zhou, L., Grattan, M., Meagher, C. T., Zucker, P., Chen, Y. H., Nagle, J. W., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1967 · Cited by 105
Cell death at the intestinal epithelial front line
Delgado, M. E., Grabinger, T., & Brunner, T. (2015) · FEBS Journal · doi:10.1111/febs.13575 · Cited by 107
Hepatitis B Virus Sensitizes Hepatocytes to TRAIL-Induced Apoptosis through Bax
Liang, X., Liu, Y., Zhang, Q., Gao, L., Han, L., Ma, C., Zhang, L., Chen, Y. H., & Sun, W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.503 · Cited by 104
Inducible Silencing of KILLER/DR5 In vivo Promotes Bioluminescent Colon Tumor Xenograft Growth and Confers Resistance to Chemotherapeutic Agent 5-Fluorouracil
Wang, S., & El‐Deiry, W. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1734 · Cited by 104
Induction of Cell Death in Human Immunodeficiency Virus-Infected Macrophages and Resting Memory CD4 T Cells by TRAIL/Apo2L
Lum, J. J., Pilon, A. A., Sanchez-Dardon, J. L., Phenix, B. N., Kim, J. E., Mihowich, J., Jamison, K., Hawley‐Foss, N., Lynch, D. H., & Badley, A. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.11128-11136.2001 · Cited by 106
Self-citation
Wogonin sensitizes resistant malignant cells to TNFα- and TRAIL-induced apoptosis
Fas, S. C., Baumann, S., Zhu, J. Y., Giaisi, M., Treiber, M. K., Mahlknecht, U., Krammer, P. H., & Li‐Weber, M. (2006) · Blood · doi:10.1182/blood-2006-03-011973 · Cited by 103
Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway
Feng, X., Jiang, J., Shi, S., Xie, H., Zhou, L. M., & Zheng, S. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3751 · Cited by 103
Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4', 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential
Shankar, S., Chen, Q., Siddiqui, I. A., Sarva, K., & Srivastava, R. K. (2007) · Journal of Molecular Signaling · doi:10.1186/1750-2187-2-7 · Cited by 103
Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Immune Response to Influenza Virus Infection in Mice
Ishikawa, E., Nakazawa, M., Yoshinari, M., & Minami, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7658-7663.2005 · Cited by 103
Flavopiridol Induces Cellular FLICE-Inhibitory Protein Degradation by the Proteasome and Promotes TRAIL–Induced Early Signaling and Apoptosis in Breast Tumor Cells
Palacios, C., Yerbes, R., & López‐Rivas, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0808 · Cited by 105
Peroxisome Proliferator-activated Receptor γ Agonists Promote TRAIL-induced Apoptosis by Reducing Survivin Levels via Cyclin D3 Repression and Cell Cycle Arrest
Lü, M., Kwan, T., Yu, C., Chen, F., Freedman, B. D., Schafer, J. M., Lee, E. J., Jameson, J. L., Jordan, V. C., & Cryns, V. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411519200 · Cited by 103
Cooperation of the proapoptotic receptor agonist rhApo2L/TRAIL with the CD20 antibody rituximab against non-Hodgkin lymphoma xenografts
Daniel, D., Yang, B., Lawrence, D. A., Tótpál, K., Balter, I., Lee, W. P., Gogineni, A., Cole, M. J., Yee, S. F., Ross, S., et al. (2007) · Blood · doi:10.1182/blood-2007-02-076075 · Cited by 102
In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis
Shah, K., Tung, C., Breakefield, X. O., & Weissleder, R. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.017 · Cited by 102
Protein-based therapeutic approaches targeting death receptors
French, L. E., & Tschopp, J. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401185 · Cited by 102
Inhibition of NF-κB Signaling by Quinacrine Is Cytotoxic to Human Colon Carcinoma Cell Lines and Is Synergistic in Combination with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) or Oxaliplatin
Jani, T. S., DeVecchio, J., Mazumdar, T., Agyeman, A., & Houghton, J. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091645 · Cited by 103
Vitamin E analogues as a novel group of mitocans: Anti-cancer agents that act by targeting mitochondria
Neužil, J., Dong, L., Ramanathapuram, L. V., Hahn, T., Chladova, M., Wang, X., Zobalová, R., Procházka, L., Gold, M., Freeman, R., et al. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.02.003 · Cited by 104
ALK‐negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects–a review
ten Berge, R. L., Oudejans, J. J., Ossenkoppele, G. J., & Meijer, C. J. L. M. (2003) · The Journal of Pathology · doi:10.1002/path.1331 · Cited by 102
On the TRAIL to apoptosis
Baetu, T. M., & Hiscott, J. B. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00006-0 · Cited by 103
Alpha fetoprotein is a novel protein‐binding partner for caspase‐3 and blocks the apoptotic signaling pathway in human hepatoma cells
Li, M., Li, H., Li, Z., Zhou, S., Guo, L., Liu, H., Jiang, W., Liu, X., Li, P., McNutt, M. A., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24272 · Cited by 101
Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway
Allen, J. E., Krigsfeld, G. S., Patel, L., Mayes, P. A., Dicker, D. T., Wu, G. S., & El‐Deiry, W. S. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0346-9 · Cited by 101
Erythroid Differentiation Sensitizes K562 Leukemia Cells to TRAIL-Induced Apoptosis by Downregulation of c-FLIP
Hietakangas, V., Poukkula, M., Heiskanen, K. M., Karvinen, J. T., Sistonen, L., & Eriksson, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1278-1291.2003 · Cited by 100
Quercetin sensitizes human hepatoma cells to TRAIL‐induced apoptosis via Sp1‐mediated DR5 up‐regulation and proteasome‐mediated c‐FLIPS down‐regulation
Kim, J. Y., Kim, E. H., Park, S. S., Lim, J. H., Kwon, T. K., & Choi, K. S. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21958 · Cited by 100
Enhanced Apoptosis and Tumor Regression Induced by a Direct Agonist Antibody to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor 2
Motoki, K., Mori, E., Matsumoto, A., Thomas, M., Tomura, T., Humphreys, R. C., Albert, V. R., Muto, M., Yoshida, H., Aoki, M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1867 · Cited by 101
Neutralization of TRAIL death pathway protects human neuronal cell line from β-amyloid toxicity
Cantarella, G., Uberti, D. L., Carsana, T., Lombardo, G. A. G., Bernardini, R., & Memo, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401143 · Cited by 100
Molecular Cross-talk between the TRAIL and Interferon Signaling Pathways
Kumar‐Sinha, C., Varambally, S., Sreekumar, A., & Chinnaiyan, A. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107795200 · Cited by 100
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells
Nesterov, A., Ivashchenko, Y., & Kraft, A. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205151 · Cited by 100
Influenza vaccines and vaccination strategies in birds
van den Berg, T., Lambrecht, B., Marché, S., Steensels, M., Borm, S. V., & Bublot, M. (2007) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2007.07.004 · Cited by 99
X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
Ng, C., & Bonavida, B. (2002) · PubMed · Cited by 99
Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer
von Pawel, J., Harvey, J. H., Spigel, D. R., Dediu, M., Reck, M., Cebotaru, C. L., Humphreys, R. C., Gribbin, M., Fox, N. L., & Camidge, D. R. (2014) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.12.005 · Cited by 99
The biology of apoptosis
Geske, F. J., & Gerschenson, L. E. (2001) · Human Pathology · doi:10.1053/hupa.2001.28250 · Cited by 100
Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells.
Huang, Y., He, Q., Hillman, M. J., Rong, R., & Sheikh, M. S. (2001) · PubMed · Cited by 99
TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity
Rossin, A., Miloro, G., & Hueber, A. (2019) · Cancers · doi:10.3390/cancers11050639 · Cited by 102
Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake
Mundt, B., Wirth, T., Zender, L., Waltemathe, M., Trautwein, C., Manns, M. P., Kühnel, F., & Kubicka, S. (2005) · Gut · doi:10.1136/gut.2004.056929 · Cited by 98
A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins
Miyazaki, T., & Reed, J. C. (2001) · Nature Immunology · doi:10.1038/88684 · Cited by 98
Malignant ascites protect against TRAIL‐induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells
Lane, D. A., Robert, V., Grondin, R., Rancourt, C., & Piché, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22840 · Cited by 97
Oral delivery of bacteria: Basic principles and biomedical applications
Li, S., Jiang, W., Zheng, C., Shao, D., Liu, Y., Huang, S., Han, J., Ding, J., Tao, Y., & Li, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.011 · Cited by 95
Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells
Mazurek, N., Byrd, J. C., Sun, Y., Hafley, M., Ramirez, K., Burks, J., & Bresalier, R. S. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.123 · Cited by 96
Simultaneous Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling and Enhanced Activation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor-mediated Apoptosis Induction by an scFv:sTRAIL Fusion Protein with Specificity for Human EGFR
Bremer, E., Samplonius, D. F., van Genne, L., Dijkstra, M. H., Kroesen, B. J., de Leij, L. F. M. H., & Helfrich, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413673200 · Cited by 96
Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB.
Yang, X., Merchant, M. S., Romero, M. E., Tsokos, M., Wexler, L. H., Kontny, U., Mackall, C. L., & Thiele, C. J. (2003) · PubMed · Cited by 96
CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release
Röhn, T. A., Wagenknecht, B., Roth, W., Naumann, U., Gulbins, E., Krammer, P. H., Walczak, H., & Weller, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204534 · Cited by 96
Self-citation
Obesity diminishes response to PD-1-based immunotherapies in renal cancer
Boi, S. K., Orlandella, R. M., Gibson, J. T., Turbitt, W. J., Wald, G., Thomas, L. J., Rosean, C. B., Norris, K. E., Bing, M. T., Bertrand, L. A., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000725 · Cited by 95
TNF‐related apoptosis‐inducing ligand as a therapeutic agent in autoimmunity and cancer
Cretney, E., Shanker, A., Yagita∥, H., Smyth, M. J., & Sayers, T. J. (2006) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01413.x · Cited by 97
Initiation factor modifications in the preapoptotic phase
Morley, S., Coldwell, M. J., & Clemens, M. J. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401591 · Cited by 96
TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation
Kim, Y., & Lee, Y. J. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21098 · Cited by 95
A Human scFv Antibody against TRAIL Receptor 2 Induces Autophagic Cell Death in Both TRAIL-Sensitive and TRAIL-Resistant Cancer Cells
Park, K.-J., Lee, S., Kim, T.-I., Lee, H.-W., Lee, C., Kim, E., Jang, J.-Y., Choi, K. S., Kwon, M., & Kim, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4766 · Cited by 95
Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand–mediated apoptosis
Leverkus, M., Walczak, H., McLellan, A. D., Fries, H.-W., Terbeck, G., Bröcker, E., & Kämpgen, E. (2000) · Blood · doi:10.1182/blood.v96.7.2628 · Cited by 95
Self-citation
CD40 Ligand Protects from TRAIL-Induced Apoptosis in Follicular Lymphomas through NF-κB Activation and Up-Regulation of c-FLIP and Bcl-xL
Travert, M., Amé-Thomas, P., Pangault, C., Morizot, A., Micheau, O., Sémana, G., Lamy, T., Fest, T., Tarte, K., & Guillaudeux, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1001 · Cited by 94
PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2
Frese, S., Pirnia, F., Miescher, D., Krajewski, S., Borner, M., Reed, J. C., & Schmid, R. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206842 · Cited by 94
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-κB activation and cFLIPL up-regulation
Bortul, R., Tazzari, P. L., Cappellini, A., Tabellini, G., Billi, A. M., Bareggi, R., Manzoli, L., Cocco, L., & Martelli, A. M. (2003) · Leukemia · doi:10.1038/sj.leu.2402793 · Cited by 94
Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis Is Inhibited by Bcl-2 but Restored by the Small Molecule Bcl-2 Inhibitor, HA 14-1, in Human Colon Cancer Cells
Sinicrope, F. A., Penington, R. C., & Tang, X. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1289 · Cited by 94
Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma
Choi, S. A., Hwang, S.-K., Wang, K.-C., Cho, B.-K., Phi, J. H., Lee, J. Y., Jung, H., Lee, D. H., & Kim, S. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq147 · Cited by 95
Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL‐mediated apoptosis of prostate cancer cells: Role of XIAP in resistance
Ng, C., Zisman, A., & Bonavida, B. (2002) · The Prostate · doi:10.1002/pros.10155 · Cited by 94
Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades, N., Poulaki, V., Tseleni‐Balafouta, S., Koutras, D. A., & Stamenkovic, I. (2000) · PubMed · Cited by 94
Beyond Radioiodine: A Review of Potential New Therapeutic Approaches for Thyroid Cancer
Braga‐Basaria, M., & Ringel, M. D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021863 · Cited by 94
Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor–related apoptosis-inducing ligand (TRAIL)–mediated cytotoxicity by selective up-regulation of TRAIL-R1
Pietro, R. D., Secchiero, P., Rana, R., Gibellini, D., Visani, G., Bemis, K., Zamai, L., Miscia, S., & Zauli, G. (2001) · Blood · doi:10.1182/blood.v97.9.2596 · Cited by 94
Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis.
Peták, I., Douglas, L., Tillman, D. M., Vernes, R., & Houghton, J. A. (2000) · PubMed · Cited by 93
Switching from aerobic glycolysis to oxidative phosphorylation modulates the sensitivity of mantle cell lymphoma cells to TRAIL
Robinson, G. L., Dinsdale, D. D., MacFarlane, M., & Cain, K. (2012) · Oncogene · doi:10.1038/onc.2012.13 · Cited by 93
Parthenolide sensitizes hepatocellular carcinoma cells to trail by inducing the expression of death receptors through inhibition of STAT3 activation
Carlisi, D., D’Anneo, A., Angileri, L., Lauricella, M., Emanuele, S., Santulli, A., Vento, R., & Tesoriere, G. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22494 · Cited by 93
Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8
SHINNOH, M., Horinaka, M., Yasuda, T., Yoshikawa, S., Morita, M., Yamada, T., Miki, T., & Sakai, T. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1790 · Cited by 94
The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer
Cousin, F., Jouan-Lanhouet, S., Théret, N., Brenner, C., Jouan, E., Moigne-Muller, G. L., Dimanche‐Boitrel, M., & Jan, G. (2016) · Oncotarget · doi:10.18632/oncotarget.6881 · Cited by 93
TRAIL and Other TRAIL Receptor Agonists as Novel Cancer Therapeutics
Falschlehner, C., Ganten, T. M., Koschny, R., Schaefer, U., & Walczak, H. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_14 · Cited by 93
Self-citation
Apoptotic Pathways in Tumor Progression and Therapy
Melet, A., Song, K., Bucur, O., Jagani, Z., Grassian, A. R., & Khosravi‐Far, R. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-1-4020-6554-5_4 · Cited by 92
Studies on search for bioactive natural products targeting TRAIL signaling leading to tumor cell apoptosis
Ishibashi, M., & Ohtsuki, T. (2008) · Medicinal Research Reviews · doi:10.1002/med.20123 · Cited by 92
Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy
Sayers, T. J., & Murphy, W. J. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0676-3 · Cited by 90
Constitutively Activated Nuclear Factor-κB, but not Induced NF-κB, Leads to TRAIL Resistance by Up-Regulation of X-Linked Inhibitor of Apoptosis Protein in Human Cancer Cells
Braeuer, S. J., Büneker, C. K., Mohr, A., & Zwacka, R. M. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0231 · Cited by 92
The Up-regulation of Human Caspase-8 by Interferon-γ in Breast Tumor Cells Requires the Induction and Action of the Transcription Factor Interferon Regulatory Factor-1
Ruiz‐Ruiz, C., de Almodóvar, C. R., Rodrı́guez, A., Ortiz-Ferrón, G., Redondo, J. M., & López‐Rivas, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313023200 · Cited by 92
Cytokines as potential biomarkers of liver toxicity
Lacour, S., Gautier, J., Pallardy, M. J., & Roberts, R. A. (2005) · Cancer Biomarkers · doi:10.3233/cbm-2005-1105 · Cited by 89
Regulation of the Extrinsic Apoptotic Pathway by MicroRNA-21 in Alcoholic Liver Injury
Francis, H., McDaniel, K. M., Han, Y., Liu, X., Kennedy, L. L., Yang, F., McCarra, J., Zhou, T., Glaser, S. S., Venter, J. K., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.602383 · Cited by 91
TRAIL therapy and prospective developments for cancer treatment
Thapa, B., Remant, K. C., & Uludağ, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.013 · Cited by 94
Spatial dynamics of TRAIL death receptors in cancer cells
Twomey, J. D., Kim, S.-R., Zhao, L., Bozza, W. P., & Zhang, B. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.02.001 · Cited by 97
Lyssavirus Matrix Protein Induces Apoptosis by a TRAIL-Dependent Mechanism Involving Caspase-8 Activation
Kassis, R., Larrous, F., Estaquier, J., & Bourhy, H. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6543-6555.2004 · Cited by 91
Therapeutic targeting of apoptosis pathways in cancer
Ziegler, D. S., & Kung, A. L. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f310f6 · Cited by 92
Protein Kinase C Modulates Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis by Targeting the Apical Events of Death Receptor Signaling
Harper, N. W., Hughes, M. A., Farrow, S. N., Cohen, G. M., & MacFarlane, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307376200 · Cited by 94
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Pathway Signaling
Thorburn, A. M. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31805fea64 · Cited by 93
Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells.
Yu, R., Mandlekar, S., Ruben, S. M., Ni, J., & Kong, A. (2000) · PubMed · Cited by 91
TRAIL mediates liver injury by the innate immune system in the bile duct–ligated mouse†
Kahraman, A., Barreyro, F. J., Bronk, S. F., Werneburg, N. W., Mott, J. L., Akazawa, Y., Masuoka, H. C., Howe, C. L., & Gores, G. J. (2008) · Hepatology · doi:10.1002/hep.22136 · Cited by 91
An introduction to death receptors in apoptosis
Kumar, R., Herbert, P. E., & Warrens, A. Ν. (2005) · International Journal of Surgery · doi:10.1016/j.ijsu.2005.05.002 · Cited by 92
Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis
Kontny, H. U., Hämmerle, K., Klein, R., Shayan, P., Mackall, C. L., & Niemeyer, C. M. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400836 · Cited by 90

Authors: Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., Smith, C., Smolak, P., Goodwin, R. G., Rauch, C. T., Schuh, J. C. L., & Lynch, D. H.
Corresponding author: Lynch, David H.
ORCID: Walczak, Henning
Miller, Robert E.
Griffith, Thomas S.
Smith, Craig
Schuh, JoAnn C.L.
Lynch, David H.
Venue: Nature Medicine
Publisher: Springer Science and Business Media LLC
Published: 1999-02
Volume: 5
Issue: 2
Pages: 157-163
ISSN: 1078-8956 (ISSN-L)
1546-170X
DOI: 10.1038/5517
OpenAlex: W1484817497
Cited by: 2,497
References: 48
Citations by year: 2026: 20 · 2025: 24 · 2024: 33 · 2023: 58 · 2022: 47 · 2021: 57 · 2020: 57 · 2019: 63 · 2018: 64 · 2017: 73 · 2016: 76 · 2015: 80 · 2014: 84 · 2013: 94 · 2012: 96
FWCI: 41.34
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Life Sciences › Immunology and Microbiology › Immunology › Toxin Mechanisms and Immunotoxins
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: TRAIL, tumor necrosis factor-related apoptosis-inducing ligand, leucine zipper, Fas ligand, apoptosis, tumor growth inhibition, hepatotoxicity, SCID mice, TNF receptor, cancer therapy
MeSH terms: Animals, Antineoplastic Agents, Dose-Response Relationship, Drug, Humans, Membrane Glycoproteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Protein Conformation, Tumor Cells, Cultured, Tumor Necrosis Factor-alpha, Mice, SCID, Apoptosis, Apoptosis Regulatory Proteins, Mice, TNF-Related Apoptosis-Inducing Ligand, Fas Ligand Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks